UBI Pharma Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Taiwan
- Registered address
- No. 45, Guangfu N. Rd., Hukou, Hsinchu 303036, Taiwan (TWN)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3004713402 · DUNS 658871159
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-06-06
- VAIDrug Quality Assurance2019-06-20
- VAIDrug Quality Assurance2014-07-18
- VAIDrug Quality Assurance2012-08-06
Drugs this plant is listed as making
11 distinct drugs across 18 products name this site in their FDA label.
- acyclovirSolco Healthcare US, LLC
- CyanocobalaminVitruvias Therapeutics
- Desmopressin Acetatein shortageDr.Reddys' Laboratories Inc
- Ephedrine SulfateFresenius Kabi USA, LLC
- epinephrineBaxter Healthcare Corporation
- leuprolide acetateUBI Pharma Inc.
- naloxone hydrochlorideBaxter Healthcare Corporation
- Norepinephrine BitartrateBreckenridge Pharmaceutical, Inc.
- OlanzapineUBI Pharma Inc.
- voriconazoleUBI Pharma Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.